BRIDGEND GROUP
MERTHYR MAWR ROAD, BRIDGEND
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 43 | 57 | 75.4% | |
| HF 4 | 2011 | 43 | 55 | 78.2% | |
| HF 4 | 2012 | 40 | 53 | 75.5% | |
| HF 4 | 2013 | 38 | 50 | 76.0% | |
| HF004W | 2014 | 8 | 8 | 100.0% | |
| HF004 | 2015 | 9 | 12 | 75.0% |
